Latest:
Dr Wang on Evolving Challenges in the Management of CRPC
Jue Wang, MD, discusses the evolving challenges in the management of castration-resistant prostate cancer.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Christopher Lieu, MD, Anschutz Medical Campus
Latest:
ASCO GI 2021: MRD Detection With ctDNA From Assays
Expert physicians discuss data presented at the ASCO GI (American Society of Clinical Oncology Gastrointestinal Cancers Symposium) 2021 annual meeting, regarding minimal residual disease (MRD) detection with ctDNA (circulating tumor DNA) from personalized assays in stage II and III patients with colorectal cancer.
UT Southwestern
Latest:
Experimental Drug Could Spur Immunotherapy Response in Patients With Non–Small Cell Lung Cancer
Research led by UT Southwestern scientists suggests that an investigational drug could restore the ability of some non–small cell lung cancers to respond to an immune checkpoint blockade, a therapy that harnesses the immune system to fight malignant tumors.
Amila Patel, PharmD, BCOP
Latest:
Digital Health and Process Improvements Enhance Community-Based Patient Care
A marked reduction in hospitalizations and emergency department visits are key metrics for value-based care programs. Quality improvement processes and electronic patient management systems may give practices a way to fully embrace these programs and remain mindful of cost while ensuring that patients receive high-quality care.
Girish Kunapareddy, MD
Latest:
The Future of CAR T-Cell Therapy in R/R DLBCL: Closing Reflections and Key Takeaways
Experts discuss the future outlook for chimeric antigen receptor T-cell therapy (CAR T) in diffuse large B-cell therapy (DLBCL), exploring potential advancements and evolving treatment strategies.